Your session is about to expire
← Back to Search
Platelet Rich Plasma
PRP for Frontal Fibrosing Alopecia
N/A
Waitlist Available
Led By Maria Hordinsky, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Willing to abstain from over the counter and prescription hair/scalp products other than those supplied in the study
Scalp biopsy consistent with frontal fibrosing alopecia diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 years
Awards & highlights
Study Summary
This trial will assess whether platelet rich plasma can help treat symptoms and promote hair growth in patients with frontal fibrosing alopecia.
Who is the study for?
This trial is for adults with frontal fibrosing alopecia, who can consent and follow the study rules. They must not be pregnant or breastfeeding, avoid certain medications and supplements, use specific shampoo, and agree to contraception if applicable. People with scalp atrophy, severe allergies, bleeding disorders or on certain treatments are excluded.Check my eligibility
What is being tested?
The trial tests platelet rich plasma (PRP) prepared using Eclipse Easy Spin centrifuge for treating frontal fibrosing alopecia. PRP will be injected into the affected scalp area to see if it reduces symptoms and promotes hair growth.See study design
What are the potential side effects?
Potential side effects may include discomfort at injection sites, risk of infection from injections, possible allergic reactions to materials used in PRP preparation or triamcinolone allergy/intolerance.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am willing to only use the hair/scalp products provided by the study.
Select...
My scalp biopsy confirmed I have frontal fibrosing alopecia.
Select...
I am able to understand and agree to the study's procedures and risks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in the LPPAI score from baseline
Changes in the hair growth from baseline to the completion of the study • Change in hair growth from baseline to study completion via investigator assessment of scalp photography
Secondary outcome measures
self-assessment using the Dermatology Quality Life Index
Trial Design
1Treatment groups
Experimental Treatment
Group I: Eclipse Easy Spin for PRP TreatmentExperimental Treatment1 Intervention
Assessing the safety and efficacy of platelet rich plasma for treating frontal fibrosing alopecia. This will be accomplished by the production of platelet rich plasma by the Eclipse Easy Spin centrifuge. Subjects will receive treatment once a month for 6 months. Platelet rich plasma will be administered via injections into the affected areas of the scalp.
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,377 Previous Clinical Trials
1,588,276 Total Patients Enrolled
1 Trials studying Frontal Fibrosing Alopecia
5 Patients Enrolled for Frontal Fibrosing Alopecia
Maria Hordinsky, MDPrincipal InvestigatorUniversity of Minnesota Department of Dermatology
16 Previous Clinical Trials
438 Total Patients Enrolled
Ronda Farah, MDPrincipal InvestigatorUniversity of Minnesota Department of Dermatology
2 Previous Clinical Trials
80 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a tendency to develop raised or thick scars.I am currently on medication that weakens my immune system.I have had other scalp or hair conditions in the past.I am currently undergoing chemotherapy or radiation.I currently have cancer.I haven't used any skin-applied steroids in the last 6 weeks.I am 18 years old or older.I am willing to use Head and Shoulders shampoo during the study.I agree to use effective birth control during the study.I have taken medication like hydroxychloroquine or prednisone in the last 3 months.I am willing to only use the hair/scalp products provided by the study.I am willing to stop taking NSAIDs, aspirin, St. John's Wort, and high doses of Vitamin E for 4 weeks.My scalp biopsy confirmed I have frontal fibrosing alopecia.I have a problem with how my blood clots.I have HIV, a connective tissue disorder, PCOS, or untreated thyroid disease.I am able to understand and agree to the study's procedures and risks.A dermatologist has diagnosed you with frontal fibrosing alopecia.My scalp is thinning.I am currently on blood thinners.You have a history of severe allergic reactions or have multiple severe allergies.You are allergic or cannot tolerate triamcinolone.I have a blood or bleeding disorder.You have an autoimmune disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Eclipse Easy Spin for PRP Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers seeking more participants for this trial?
"Unfortunately, this particular trial is not recruiting new patients at this time. According to the information found on clinicaltrials.gov, this study was first posted on November 1st, 2020 and was last updated on February 28th, 2020. Although this trial is no longer enrolling patients, there are 92 other trials which are still looking for participants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger